跳至主要内容
临床试验/NCT01518829
NCT01518829已完成不适用

Role of Procalcitonin in Differantiation Between Bacerial Infection and Non Infectious Inflammation in Febrile Hepatocellular Carcinoma Patients After Locoregional Treatment

Ain Shams University1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2012年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
42
试验地点
1
主要终点
Differantiate between post- embolization syndrom and sepsis following locoregional treatment for hepatocellular carcinoma

研究概览

简要总结

the value of serum procalcitonin in differentiation between bacterial infection and non infectious inflammation in febrile HCC patients following locoeregional treatment for HCC.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hepatocellular carcinoma patients who will undergo TACE and/or radio-frequency.
  • Fever more than 38C after 48 hours post intervention.

排除标准

  • HCC Patients who does not develop fever after intervention.
  • Proven infection elsewhere (e.g. UTI, chest infection..)

结局指标

主要结局

Differantiate between post- embolization syndrom and sepsis following locoregional treatment for hepatocellular carcinoma

时间窗: 6months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Iman Fawzy Montasser

Lecturer of Tropical medicine ,Faculty of Medicine,Ain Shams university

Ain Shams University

研究点 (1)

Loading locations...

相似试验